Kardiovaskuläres Risikomanagement bei Typ-1-Diabetes – Kontinuierliche umfassende Betreuung

Melden Sie sich bitte hier kostenlos und unverbindlich an, um den Inhalt vollständig einzusehen und weitere Services von www.medmedia.at zu nutzen.

Zur Anmeldung

AutorIn: Prim. Univ.-Prof. Dr. Monika Lechleitner

ö. Landeskrankenhaus Hochzirl – Anna-Dengel-Haus

1 The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the ESC and developed in collaboration with the EASD: ESC Guidelines on diabetes, pre-diabetes and cardiovascular diseases developed in collaboration with the EASD. European Heart Journal 2013; 34:3035–3087

2 Laing SP et al., Mortality from heart disease in a cohort of 23,000 patients with insulin treated diabetes. Diabetologia 2003; 46:760–765

3 Duca L, Sippl R, Snell-Bergeon JK, Is the risk and nature of CVD the same in type 1 and type 2 diabetes? Curr Diab Rep 2013; 13:350–361

4 Eeg-Olofson K, Cederholm J, Nilsson PM et al., Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes. Diabetes Care 2010, 33:1640–1646

5 McVeigh GE, Gibson W, Hamilton PK, Cardiovascular risk in young type 1 diabetes population with a low 10-year, but high lifetime risk of cardiovascular disease. Diabetes, Obesity and Metabolism 2012; 15:198–203

6 Margeirsdottir HD, Larsen JR, Brunborg C et al.,

Norwegian Study Group for Childhood Diabetes. High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population based study. Diabetologia 2008; 51:554–561

7 ADA, Standards of medical care in diabetes 2014. Diabetes Care 2014; S1:14–80

8 The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 years: overview, Diabetes Care 2014

9 Orchard TJ et al., In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 2001; 53:2312–2319

10 Mooradian AD, Haas MJ, Wong NC, Transcriptional control of apolipoprotein A-1 gene expression in diabetes. Diabetes 2004; 53:513–520

11 Scott LJ et al., A non-linear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes. Diabetes 2001; 50:2842–2846

12 Gerber PA et al., Smoking is associated with impaired long-term glucose metabolism in patients with type 1 diabetes mellitus. Nat Metab Cardiovasc Dis 2013; 23:102–108

13 Chillaron JJ et al., Type 1 diabetes, metabolic syndrome and cardiovascular risk. Metabolism 2014, available online

14 Cleveland SJ, Cardiovascular risk in double diabetes mellitus-when two worlds collidie. Nat Rev Endocrinol 2010; 8:476–485

15 Purnell JQ et al., The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Circulation 2013; 127:180–187

16 Leroux C et al., Lifestyle and cardiometabolic risk in adults with type 1 diabetes: a review. Can J Diabetes 2014; 38:62–69

UIM 06|2014

Herausgeber: o. Univ.-Prof. Dr. Günter J. Krejs, Österreichische Gesellschaft für Innere Medizin
Publikationsdatum: 2014-08-04